Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients

Ractigen News

Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients
TherapeuticsReceivesIND
  • 📰 TheManilaTimes
  • ⏱ Reading Time:
  • 26 sec. here
  • 19 min. at publisher
  • 📊 Quality Score:
  • News: 73%
  • Publisher: 92%

SUZHOU, China, May 15, 2024 PRNewswire -- Ractigen Therapeutics, a clinical-stage pharmaceutical company committed to developing pioneering therapies, today announces that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for the initiation of...

SUZHOU, China, May 15, 2024 PRNewswire -- Ractigen Therapeutics , a clinical-stage pharmaceutical company committed to developing pioneering therapies, today announces that the Center for Drug Evaluation of China's National Medical Products Administration has approved the Investigational New Drug application for the initiation of Phase 1 clinical trials in China for RAG-17 , targeting Amyotrophic Lateral Sclerosis .

Additionally, an Investigator-Initiated Trial study for RAG-17 is currently ongoing, with 6 patients recruited and treated, showing encouraging preliminary safety and efficacy results.About RAG-17RAG-17 is a therapeutic siRNA specifically designed to suppress the SOD1 gene in ALS patients with pathogenic mutations. Utilizing Ractigen's proprietary SCAD™ delivery platform, RAG-17 combines siRNA with an accessory oligonucleotide for enhanced effectiveness in central nervous system tissues.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TheManilaTimes /  🏆 2. in PH

Therapeutics Receives IND Approval From China's NMPA To Initiate Phase Clinical Trials For RAG-17 In SOD1-ALS Patients

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

China military says it ‘drove away’ US destroyer in South China SeaChina military says it ‘drove away’ US destroyer in South China SeaThe US Navy says its destroyer asserted navigational rights and freedoms in the South China Sea near the Paracel Islands 'consistent with international law'
Read more »

China military says it ‘drove away’ US destroyer in South China SeaChina military says it ‘drove away’ US destroyer in South China SeaThe US Navy says its destroyer asserted navigational rights and freedoms in the South China Sea near the Paracel Islands 'consistent with international law'
Read more »

China says tailed, 'issued a warning' to US Navy ship in South China SeaBeijing's military on Friday said it had tailed and issued a warning to a US Navy ship near the Paracel Islands in the disputed South China Sea.
Read more »

Germany sends two warships to Indo-Pacific amid China and Taiwan, South China Sea tensionsGermany sends two warships to Indo-Pacific amid China and Taiwan, South China Sea tensionsGermany sent two warships to the Indo-Pacific region in a bid to strengthen its military presence in the region amid rising tensions between China and Taiwan and over the South China Sea.
Read more »

View from Manila: Why isn’t China confirming the next South China Sea meeting with Philippines?View from Manila: Why isn’t China confirming the next South China Sea meeting with Philippines?In President Marcos' home province, Ilocos Norte, PH and US troops play out an invasion scenario and sink a China-made oil tanker for Balikatan 2024
Read more »

US slams China’s ‘irresponsible behavior’ in South China SeaDamage to Philippine vessels and injuries to their crew in the South China Sea constitute “irresponsible behavior” in disregard of international law, US Defense Secretary Lloyd Austin said on Thursday, weighing in on the latest flare-up involving China.
Read more »



Render Time: 2025-08-28 21:15:59